PDCD1 and cancer: The work of James P. Allison and Tasuku Honjo on cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) for cancer therapy was awarded with the Nobel Prize in Physiology or Medicine in 2018 (www.nobelprize.org).